एपीए उद्धरण

FUJIWARA, Y., YOSHIKAWA, R., KAMIKONYA, N., NAKAYAMA, T., KITANI, K., TSUJIE, M., . . . YAMAMURA, T. (2012). Trimodality therapy of esophagectomy plus neoadjuvant chemoradiotherapy improves the survival of clinical stage II/III esophageal squamous cell carcinoma patients. D.A. Spandidos.

शिकागो स्टाइल उद्धरण

FUJIWARA, YOSHINORI, REIGETSU YOSHIKAWA, NORIHIKO KAMIKONYA, TSUYOSHI NAKAYAMA, KOTARO KITANI, MASANORI TSUJIE, MASAO YUKAWA, MASATOSHI INOUE, और TAKEHIRA YAMAMURA. Trimodality Therapy of Esophagectomy Plus Neoadjuvant Chemoradiotherapy Improves the Survival of Clinical Stage II/III Esophageal Squamous Cell Carcinoma Patients. D.A. Spandidos, 2012.

एमएलए उद्धरण

FUJIWARA, YOSHINORI, et al. Trimodality Therapy of Esophagectomy Plus Neoadjuvant Chemoradiotherapy Improves the Survival of Clinical Stage II/III Esophageal Squamous Cell Carcinoma Patients. D.A. Spandidos, 2012.

चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.